DGS is responsible for convening the CPC, a statewide collaborative that includes 7 Executive Sponsors (state agencies) and 15 Member Agencies (state and local governmental agencies). Represented agencies reflect buyers and payers of prescription drugs. The CPC leads the discussion for California governmental agencies to come up with solutions to improve the cost of pharmaceuticals for the State of CA. Angela Shell, DGS Deputy Director of Procurement, is chair of this committee. 

CPC coordinates the efforts of state and local governmental entities to reduce pharmaceutical expenditures. CPC facilitates the collaboration of Member Agencies to: 

  • Share information
  • Identify and address obstacles and issues
  • Leverage data and communicate findings 
  • Identify, prioritize, and implement strategies for cost savings

The goal of CPC is to control costs related to pharmaceuticals for CPC Member Agencies.  In order to accomplish this goal, CPC will focus on three priority areas, procurement, policy, and participation.

1. Joint solicitations and pricing agreements.  Efforts in this area include research into viable strategies and partnerships for joint solicitations and pricing agreements as well as contract development and execution.

2. Policy and regulations.  Efforts in this area include legislative recommendations that focus on the pharmaceutical industry and enhance CPC efforts.

3. Increase in CPC participation.  Efforts in this area include the recruitment of other governmental agencies to increase volume purchasing power and the sharing of information (e.g., contracting, procurement, pricing information, best practices) among CPC member agencies.

Executive Sponsors

Executive Sponsors direct the Collaborative to meet, collaborate, discuss, and inform policy on critical issues relating to pharmaceuticals.
The Executive Sponsors are:

  • California Department of Corrections and Rehabilitation (CDCR)
  • California Department of Veterans Affairs (CalVet)
  • California Health and Human Services Agency (CHHS)
  • Department of Finance (DOF)
  • Government Operations Agency (GovOps)
  • Labor and Workforce Development Agency



All Executive Sponsors are Member Agencies. Additional Member Agencies shall serve at the pleasure of the Executive Sponsors. Each Member Agency shall appoint at least one representative to the Collaborative who shall participate in quarterly meetings as well as work-group meetings, as appropriate.
Current Member Agencies other than Executive Sponsors are:

  • California Correctional Health Care Services (CCHCS)
  • California Department of Industrial Relations (DIR)
  • California Department of Public Health (CDPH)
  • California Public Employees' Retirement System (CalPERS)
  • California State Association of Counties (CSAC)
  • California State University (CSU)
  • Covered California (CC)
  • Department of Developmental Services (DDS)
  • Department of General Services (DGS)
  • Department of Health Care Services (DHCS)
  • Department of Managed Health Care (DMHCS
  • Department of State Hospitals (DSH)
  • University of California (UC)

The Executive Sponsors or Member Agencies may request that additional state, local,
and other governmental entities who are eligible to participate in the Collaborative
become Member Agencies.


The Collaborative shall:

  • Coordinate best-value clinical treatment protocols among Collaborative members.
  • Leverage state, local and other government efficiencies and methodologies to achieve best-value procurement, purchasing, and negotiation with manufacturers for discounts on pharmaceuticals.
  • Establish and monitor performance and quality standards for protocols, guidelines, and contracts created for Member Agencies.
  • Work with member departments to track state expenditures on specified high-cost drugs to inform the budget process.
  • Recommend high-cost pharmaceuticals for cost-value review by independent research organizations.
  • Track new pharmaceuticals under Food and Drug Administration review, those likely to come out onto the market in the near future, and
    those that may become high cost.
  • Act as a discussion forum where pharmaceutical issues of interest can
    be identified and addressed.

Roles and Responsibilities

Member agencies's representatives

Representatives will:

  • Act as a conduit between their agencies and the Collaborative to facilitate the sharing and understanding of information.
  • Identify and raise issues for discussion and resolution.
  • Receive, review, recommend, and report on issues.
  • Advise the Collaborative on behalf of their represented agency

If a representative will be absent from any meeting, he/she should provide a substitute on behalf of the Member Agency.


A staff person from the DGS Pharmaceutical Acquisitions Section shall serve as
facilitator for the Collaborative. This person will:

  • Coordinate with the Executive Sponsors to ensure agendas and supporting documentation are provided to Collaborative Members five (5) days prior to the next scheduled meeting.
  • Produce meeting notes, or coordinate with the assigned meeting note-taker to do so.
  • Maintain membership distribution list, arrange meetings, and provide other support to the Collaborative as needed.



Formal decisions of the Collaborative must be made by consensus. The input and ideas of all participants are gathered and synthesized to arrive at a final decision supportable by all Member Agencies.



Workgroups shall be established as needed to support the mission and goals of the Collaborative. The Collaborative shall provide appropriate resources, oversight and direction to workgroups formed. The Collaborative shall, at a minimum, maintain the following workgroups that will meet at least quarterly:

  • Clinical Workgroup
  • Procurement Workgroup
  • Policy Workgroup
  • Local Outreach Workgroup


Stakeholder Engagement

The Collaborative shall convene public meetings at least twice annually and maintain a stakeholder list.


Annual Review

The Collaborative Members will review this Outline on an annual basis and make any
recommendations for significant Outline amendments and revisions to the Executive


Statewide Pharmaceutical Program

Department of General Services
Procurement Division

707 Third Street, Second Floor
West Sacramento, CA 95605

Edward Achuck, Pharmaceutical Program Consultant
(916) 375-4672

Vimbai Kajese, Health Program Manager II
(916) 375-4926

Ronny Chiu, Pharmaceutical Consultant II
(916) 375-4369

Mark Harlan, Health Program Specialist II
(916) 375-4558